Objective:To determine whether increased levels of maternal serum total activin A and inhibin A in preeclampsia are related to total blood volume, urinary clearance, or placental production.
Study Design:Activin A and inhibin A levels were measured in preeclamptic subjects and matched normotensive gravidas. In a subset of preeclamptic subjects (n = 21) and controls (n = 30), we performed blood volume studies. In an overlapping subject of preeclamptic subjects (n = 56), creatinine clearance results were available. Placental tissue was obtained from six preeclamptics and matched normotensive gravida for analysis of activin A and inhibin A mRNA expression.
Results:Maternal serum levels of inhibin A but not activin A were significantly negatively correlated with blood volume in preeclampsia (r2 = .26, P = 0.17, and r2 = .02, P = .44, respectively). Levels of both proteins were negatively correlated to creatinine clearance (r2 = .29, P < .0001, and r2 = .15, P = .003, respectively). Placental mRNA expression for both the α and βA subunits was increased in preeclampsia (P = .038 and .049, respectively).
Conclusion:Although placental mRNA expression of the subunits for both analytes is increased in preeclampsia, the increased levels of activin A appear to be more specifically a reflection of increased placental production than do the increased levels of inhibin A.
1. Knight PG. Roles of inhibins, activins, and follistatin in the female reproductive system. Front Neuroendocrinol1996;17:476-509.
2.
2. Wallace EM, Healy DL. Inhibins and activins: Roles in clinical practice. Br J Obstet Gynaecol1996;103:945-956.
3.
3. Petraglia F, Luisi S, Benedetto C, Zonca M, Florio P, Casarosa E, et al. Changes of dimeric inhibin B levels in maternal serum throughout healthy gestation and in women with gestational diseases. J Clin Endocrinol Metab1997;82:2991-2995.
4.
4. Petraglia F, Garuti GC, Calza Roberts V, Giardino L, et al. Inhibin subunits in human placenta: Localization and messenger ribonucleic acid level during pregnancy. Am J Obset Gynecol1991;3:750-758.
5.
5. Silver HM, Seebeck M, Carlson R. Comparison of total blood volume in normal, preeclamptic, and nonproteinuric gestational hypertensive pregnancy by simultaneous measurement of red blood cell and plasma volumes. Am J Obstet Gynecol1998;179:87-93.
6.
6. Silver HM, Seebeck MA, Cowett RM, Patterson KY, Veillon C. Red cell volume determination using a stable isotope of chromium. J Soc Gynecol Invest1997;4:254-258.
7.
7. Nielsen MH, Nielsen NC. Spectrophotometric determination of Evans blue dye in plasma with individual correction for blank density by a modified Gaeblers method. Scand J Clin Lab Invest1962;14:605-617.
8.
8. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem1987;162:156-159.
9.
9. Mason AJ, Niall HD, Seeburg PH. Structure of two human ovarian inhibins. Biochem Biophys Res Commun1986;135:957-964.
10.
10. Stewart AG, Milborrow HM, Ring JM, Crowther CE, Forage RG. Human inhibin genes: Genomic characterisation and sequencing. FEBS Lett1986;206:329-334.
11.
11.Ercolani L, Florence B, Denaro M, Alexander M. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem1988;263:15335-15341.
12.
12. Silver HM, Lambert-Messerlian GM, Star JA, Hogan J, Canick JA. Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies. Am J Obstet Gynecol1999;180:1131-1137.
13.
13. Petraglia F, Aguzzoli L, Gallinelli A, Florio P. Zonca M, Benedetto C, et al. Hypertension in pregnancy: Changes in activin A maternal serum concentration Placenta1995;16:447-454.
14.
14. Muttukrishna S, Knight PG, Groome NP, Redman CWG, Ledger WL. Activin A and inhibin A as possible endocrine markers for pre-eclampsia. Lancet1997;349:1285-1288.
15.
15. Aquilina J, Barnett A, Thompson O, Harrington K. Second-trimester maternal serum inhibin A concentration as an early marker for preeclampsia. Am J Obstet Gynecol1999;181:131-136.
16.
16. Cuckle H, Sehmi I, Jones R. Maternal serum inhibin A can predict pre-eclampsia. Br J Obstet Gynaecol1998;105:1101-1103.
17.
17. Raty R, Koskinen P, Alanen A, Irjala K, Matinlauri I, Ekblad U. Prediction of pre-eclampsia with maternal mid-trimester total renin, inhibin A, AFP and free beta-hCG levels. Prenat Diagn1999;19:122-127.
18.
18. Lambert-Messerlian GM, Silver HM, Petraglia F, Luisi S, Pezzani I, Maybruck WM, et al. Second-trimester levels of maternal serum human chorionic gonadotropin and inhibin A as predictors of preeclampsia in the third trimester. J Soc Gynecol Investig2000;7:170-174.
19.
19. De Kretser D, Hedger MP, Phillips DJ. Activin A and follistatin: Their role in the acute phase reaction and inflammation. J Endocrinol2000;161:195-198.
